Literature DB >> 14618158

Raft disorganization leads to reduced plasmin activity in Alzheimer's disease brains.

Maria Dolores Ledesma1, José Abad-Rodriguez, Cristian Galvan, Elisa Biondi, Pilar Navarro, Andre Delacourte, Colin Dingwall, Carlos G Dotti.   

Abstract

The serine protease plasmin can efficiently degrade amyloid peptide in vitro, and is found at low levels in the hippocampus of patients with Alzheimer's disease (AD). The cause of such paucity remains unknown. We show here that the levels of total brain plasminogen and plasminogen-binding molecules are normal in these brain samples, yet plasminogen membrane binding is greatly reduced. Biochemical analysis reveals that the membranes of these brains have a mild, still significant, cholesterol reduction compared to age-matched controls, and anomalous raft microdomains. This was reflected by the loss of raft-enriched proteins, including plasminogen-binding and -activating molecules. Using hippocampal neurons in culture, we demonstrate that removal of a similar amount of membrane cholesterol is sufficient to induce raft disorganization, leading to reduced plasminogen membrane binding and low plasmin activity. These results suggest that brain raft alterations may contribute to AD by rendering the plasminogen system inefficient.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14618158      PMCID: PMC1326416          DOI: 10.1038/sj.embor.7400021

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  20 in total

Review 1.  Apolipoprotein E receptors: linking brain development and Alzheimer's disease.

Authors:  J Herz; U Beffert
Journal:  Nat Rev Neurosci       Date:  2000-10       Impact factor: 34.870

Review 2.  The plasminogen (fibrinolytic) system.

Authors:  D Collen
Journal:  Thromb Haemost       Date:  1999-08       Impact factor: 5.249

3.  Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons.

Authors:  M Simons; P Keller; B De Strooper; K Beyreuther; C G Dotti; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 4.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

5.  Brain plasmin enhances APP alpha-cleavage and Abeta degradation and is reduced in Alzheimer's disease brains.

Authors:  M D Ledesma; J S Da Silva; K Crassaerts; A Delacourte; B De Strooper; C G Dotti
Journal:  EMBO Rep       Date:  2000-12       Impact factor: 8.807

6.  The plasmin system is induced by and degrades amyloid-beta aggregates.

Authors:  H M Tucker; M Kihiko; J N Caldwell; S Wright; T Kawarabayashi; D Price; D Walker; S Scheff; J P McGillis; R E Rydel; S Estus
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

7.  Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice.

Authors:  Jian-Sheng Gong; Mariko Kobayashi; Hideki Hayashi; Kun Zou; Naoya Sawamura; Shinobu C Fujita; Katsuhiko Yanagisawa; Makoto Michikawa
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

Review 8.  Annexin II and regulation of cell surface fibrinolysis.

Authors:  K A Hajjar; S S Acharya
Journal:  Ann N Y Acad Sci       Date:  2000-05       Impact factor: 5.691

9.  Proteomic characterisation of neuronal sphingolipid-cholesterol microdomains: role in plasminogen activation.

Authors:  Maria Dolores Ledesma; Jorge Santos Da Silva; Anna Schevchenko; Matthias Wilm; Carlos G Dotti
Journal:  Brain Res       Date:  2003-10-10       Impact factor: 3.252

10.  Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts.

Authors:  Robert Ehehalt; Patrick Keller; Christian Haass; Christoph Thiele; Kai Simons
Journal:  J Cell Biol       Date:  2003-01-06       Impact factor: 10.539

View more
  41 in total

1.  Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.

Authors:  Manel G Medina; Maria Dolores Ledesma; Jorge E Domínguez; Miguel Medina; Delia Zafra; Francesc Alameda; Carlos G Dotti; Pilar Navarro
Journal:  EMBO J       Date:  2005-04-21       Impact factor: 11.598

2.  Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathways.

Authors:  Pavel Michal; Vladimír Rudajev; Esam E El-Fakahany; Vladimír Dolezal
Journal:  Eur J Pharmacol       Date:  2009-01-29       Impact factor: 4.432

3.  High fat diet exacerbates neuroinflammation in an animal model of multiple sclerosis by activation of the Renin Angiotensin system.

Authors:  Silke Timmermans; Jeroen F J Bogie; Tim Vanmierlo; Dieter Lütjohann; Piet Stinissen; Niels Hellings; Jerome J A Hendriks
Journal:  J Neuroimmune Pharmacol       Date:  2013-09-26       Impact factor: 4.147

4.  Knockout of plasminogen activator inhibitor 1 gene reduces amyloid beta peptide burden in a mouse model of Alzheimer's disease.

Authors:  R-M Liu; T van Groen; A Katre; D Cao; I Kadisha; C Ballinger; L Wang; S L Carroll; L Li
Journal:  Neurobiol Aging       Date:  2009-07-14       Impact factor: 4.673

Review 5.  Alzheimer disease--no target for statin treatment. A mini review.

Authors:  Siegfried Hoyer; Peter Riederer
Journal:  Neurochem Res       Date:  2006-10-25       Impact factor: 3.996

6.  Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro.

Authors:  Mauricio G Martin; Simona Perga; Laura Trovò; Andrea Rasola; Pontus Holm; Tomi Rantamäki; Tibor Harkany; Eero Castrén; Federica Chiara; Carlos G Dotti
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

7.  Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis?

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Mol Neurodegener       Date:  2010-09-15       Impact factor: 14.195

8.  Increased expression of cholesterol transporter ABCA1 is highly correlated with severity of dementia in AD hippocampus.

Authors:  Afia Akram; James Schmeidler; Pavel Katsel; Patrick R Hof; Vahram Haroutunian
Journal:  Brain Res       Date:  2010-01-14       Impact factor: 3.252

9.  The comprehensive native interactome of a fully functional tagged prion protein.

Authors:  Dorothea Rutishauser; Kirsten D Mertz; Rita Moos; Erich Brunner; Thomas Rülicke; Anna Maria Calella; Adriano Aguzzi
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

10.  Age-dependent increase in desmosterol restores DRM formation and membrane-related functions in cholesterol-free DHCR24-/- mice.

Authors:  Katrin Kuehnle; Maria D Ledesma; Lucie Kalvodova; Alicia E Smith; Arames Crameri; Fabienne Skaanes-Brunner; Karin M Thelen; Luka Kulic; Dieter Lütjohann; Frank L Heppner; Roger M Nitsch; M Hasan Mohajeri
Journal:  Neurochem Res       Date:  2008-12-25       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.